Abacus Wealth Partners LLC Makes New Investment in Xylem Inc. $XYL

Abacus Wealth Partners LLC purchased a new position in Xylem Inc. (NYSE:XYL) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 12,215 shares of the industrial products company’s stock, valued at approximately $1,663,000.

A number of other large investors have also bought and sold shares of XYL. State of Wyoming grew its position in Xylem by 10.4% during the third quarter. State of Wyoming now owns 756 shares of the industrial products company’s stock valued at $112,000 after buying an additional 71 shares during the period. Orion Porfolio Solutions LLC increased its holdings in Xylem by 1.0% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock worth $1,151,000 after acquiring an additional 74 shares in the last quarter. Journey Strategic Wealth LLC increased its holdings in Xylem by 1.5% in the 3rd quarter. Journey Strategic Wealth LLC now owns 5,107 shares of the industrial products company’s stock worth $753,000 after acquiring an additional 77 shares in the last quarter. Quest Investment Management LLC increased its holdings in Xylem by 1.0% in the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after acquiring an additional 77 shares in the last quarter. Finally, Keel Point LLC increased its holdings in Xylem by 4.6% in the 3rd quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock worth $263,000 after acquiring an additional 79 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Xylem

In related news, Director Jerome A. Peribere acquired 1,210 shares of Xylem stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. The Goldman Sachs Group set a $158.00 price target on shares of Xylem in a report on Wednesday, February 11th. Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Royal Bank Of Canada cut their price target on shares of Xylem from $176.00 to $162.00 and set an “outperform” rating for the company in a report on Wednesday, February 11th. TD Cowen reissued a “hold” rating on shares of Xylem in a report on Monday, February 23rd. Finally, Mizuho set a $138.00 price target on shares of Xylem in a report on Wednesday, February 11th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, Xylem has an average rating of “Moderate Buy” and a consensus target price of $152.77.

Xylem Stock Down 1.2%

NYSE XYL opened at $108.17 on Friday. The business has a fifty day moving average price of $120.40 and a 200 day moving average price of $132.66. Xylem Inc. has a one year low of $108.04 and a one year high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The company has a market cap of $25.71 billion, a P/E ratio of 26.91, a P/E/G ratio of 1.54 and a beta of 1.08.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm had revenue of $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the prior year, the company earned $1.03 EPS. The firm’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts anticipate that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem declared that its Board of Directors has approved a share buyback program on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the industrial products company to reacquire up to 4.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its stock is undervalued.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.